Navigation Links
Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief

Nuclear medicine combines computers, detectors and radioactive substances called radioisotopes to produce images of blood flow and biochemical functions in the heart and other organs//. What makes the procedure so valuable is that it is possible to obtain the required information without disturbing the normal bodily functions.

Ever since the introduction of nuclear medicine in diagnosis, it has been possible to identify any structural and functional abnormality in various organs.

It has now been demonstrated for the first time that an experimental radioactive compound can show images of heart damage up to 30 hours after a brief interruption of blood flow and oxygen.

The heart normally uses fatty acid as its primary fuel source for energy. Decreased blood flow to the heart, caused either by narrowed or clogged arteries or increased demand on the heart during strenuous exercise, sets off a metabolic disturbance that slows down or halts the way fatty acid is normally utilized. The condition is called myocardial ischemia. The disturbance causes the heart to switch from fatty acid as its primary fuel to glucose.

The new tracer test keys in on this metabolic disturbance and seemingly remembers the imprint of an episode of reduced blood flow long after the episode, a process that is called "ischemic memory. When the heart is being imaged, there is a representation of the reduced fatty acid metabolism that aids diagnosis.

The radioactive tracer evaluated for this study, known by the brand name Zemiva, links a fatty acid to a radioisotope which is injected in the patient. The researchers used a technique called SPECT (Single Photon Emission Computed Tomography) to evaluate the tracer in this study.

The discovery may help physicians in emergency rooms and in their offices determine whether a patient's chest pain, which may have subsided hours earlier, is related to heart disease or something else, such as indiges tion.

This probe provides a direct connection to the cause of the chest pain without requiring a treadmill stress test or use of a drug that produces stress to assess heart function, according to researchers. Additional testing will be required before this new agent can be approved by the U.S. Food and Drug Administration.
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. The Best Way To Relieve Chest Pain
3. The Options For Relieving Chest Pain In the Elderly Questioned
4. The Link Between Migraines And Chest Pain
5. Arjun Singh In Hospital After Chest Pains
6. Freedom Fighter And Orissa Congress Leader Dies Of Chest Pain
7. Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy
8. Arrow Embedded In Tribal’s Chest For Two Weeks Surgically Remove
9. Nutrition Increases Chest Circumference among Chinese Women
10. Manual vs. Automated Chest Compression After Cardiac Arrest
11. Chest X-Rays Could Increase Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has ... the Atlanta Football Host Committee (AFHC) for the 2018 College ... Jan. 8, 2018, at Mercedes-Benz Stadium in Atlanta, ... of the AFHC "I,m In" campaign, participating in many activities ... ...
Breaking Medicine Technology: